RadNet, Inc. splits its revenue 2 ways in its filings. By operating segments, the largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Imaging Centers at $601.8 million, 97% of the total. By sales mix, the largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Commercial Insurance1 at $339.4 million, 55% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Jun 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
Q3 FY2024
Sep 30, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2,269
|
623
|
576
|
548
|
523
|
498
|
471
|
477
|
461
|
| Operating segments | |||||||||
| Imaging Centers |
2,198
+17.7%
share 96.9%
|
602
+23.5%
share 96.6%
|
557
+20.7%
share 96.7%
|
531
+13.8%
share 96.9%
|
508
+12.4%
share 97.2%
|
487
share 97.8%
|
461
share 97.9%
|
466
share 97.8%
|
452
share 98.1%
|
| Digital Health |
71
+74.4%
share 3.1%
|
21
+89.8%
share 3.4%
|
19
+87.8%
share 3.3%
|
17
+58.0%
share 3.1%
|
15
+66.7%
share 2.8%
|
11
share 2.2%
|
10
share 2.1%
|
11
share 2.2%
|
9
share 1.9%
|
| Sales mix | |||||||||
| Commercial Insurance1 |
1,244
+17.1%
share 54.8%
|
339
+21.7%
share 54.5%
|
316
+20.3%
share 54.9%
|
301
+13.2%
share 54.9%
|
288
+12.7%
share 55.0%
|
279
share 56.0%
|
262
share 55.7%
|
266
share 55.7%
|
255
share 55.4%
|
| Medicare1 |
540
+23.0%
share 23.8%
|
151
+29.6%
share 24.2%
|
137
+26.8%
share 23.8%
|
129
+15.4%
share 23.6%
|
123
+19.8%
share 23.6%
|
116
share 23.3%
|
108
share 23.0%
|
112
share 23.5%
|
103
share 22.3%
|
| Other Payors |
132
+19.9%
share 5.8%
|
37
+25.3%
share 5.9%
|
34
+21.3%
share 5.8%
|
32
+14.5%
share 5.8%
|
30
+18.1%
share 5.7%
|
29
share 5.9%
|
28
share 5.9%
|
28
share 5.8%
|
25
share 5.5%
|
| Capitation Arrangements |
124
-2.7%
share 5.5%
|
30
-0.1%
share 4.8%
|
30
-5.1%
share 5.3%
|
32
+1.1%
share 5.8%
|
31
-6.3%
share 6.0%
|
30
share 6.1%
|
32
share 6.8%
|
32
share 6.6%
|
34
share 7.3%
|
| Medicaid1 |
56
+18.7%
share 2.5%
|
14
+14.7%
share 2.3%
|
14
+19.7%
share 2.4%
|
14
+17.3%
share 2.6%
|
13
+23.6%
share 2.6%
|
13
share 2.5%
|
12
share 2.5%
|
12
share 2.5%
|
11
share 2.4%
|
| Health Care Management Service |
30
+16.6%
share 1.3%
|
8
+17.5%
share 1.3%
|
7
+19.1%
share 1.3%
|
8
+16.9%
share 1.4%
|
7
+12.9%
share 1.3%
|
7
share 1.3%
|
6
share 1.3%
|
6
share 1.3%
|
6
share 1.4%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- RDNT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Angeles, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 790526
- Former names
- RadNet, Inc. (until Oct 26, 2026); PRIMEDEX HEALTH SYSTEMS INC (until Nov 21, 2006)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- BillionToOne, Inc. BLLN
- CareDx, Inc. CDNA
Source: SEC EDGAR filings. This is company-reported data, not investment advice.